Search

Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More

BIO ROUNDUP: ROCHE-SPARK DRAGS ON, GSK TAPS CRISPR, DIABETES NEWS & MORE

Is one of the bigger biopharma acquisitions of the year in trouble? This past week, antitrust regulators once again delayed Roche's...

LILLY PLANS PHASE 2B NASH TRIAL OF DUAL GIP, GLP-1 AGONIST

Eli Lilly is planning to test its closely watched diabetes drug tirzepatide in a phase 2b nonalcoholic steatohepatitis trial. The expansion...

 
 
 
 
 
 
This Wine Grape-Infused Water Is a Low-Calorie Alternative to That Glass of Chardonnay

THIS WINE GRAPE-INFUSED WATER IS A LOW-CALORIE ALTERNATIVE TO THAT GLASS OF CHARDONNAY

In today's booze news, nonalcoholic "wine" water exists, and we are very intrigued. Steeped with wine grape skins and seeds in a process...

Make Room in Your Refrigerator! Trader Joe's New Sparkling Watermelon Juice Is Only $1

MAKE ROOM IN YOUR REFRIGERATOR! TRADER JOE'S NEW SPARKLING WATERMELON JUICE IS ONLY $1

If you ask me, Summer is a time to indulge in fresh fruit, from sweet mangoes to juicy watermelon and tart cherries. Now, Trader Joe's...

 
 
 

REGULUS TO PRESENT PRECLINICAL EFFICACY DATA HIGHLIGHTING POTENTIAL OF NOVEL TREATMENT FOR NONALCOHOLIC STEATOHEPATITIS AT THE INTERNATIONAL LIVER CONGRESS 2019

Favorable Pharmacological Properties Exhibited in Preclinical Models of NASH LA JOLLA, Calif., April 8, 2019 /PRNewswire/ - Regulus...

 
 
 
Beer Candy, Anyone? These Jelly Beans Are All About Flavor - Without Any of the Alcohol!

BEER CANDY, ANYONE? THESE JELLY BEANS ARE ALL ABOUT FLAVOR - WITHOUT ANY OF THE ALCOHOL!

Just when you thought you'd seen every flavor of jelly bean imaginable, Jelly Belly released entire cans of beer-flavored jelly beans...

Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre

NOVARTIS ADDS INFLAMMATION DRUGS TO PIPELINE WITH DEAL FOR IFM TRE

Less than a year after launching and only days after advancing its lead program into clinical trials, drug developer IFM Tre is in...

 
 
 
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More

BIO ROUNDUP: AMYLOID ANGST, NASH NEWS, BRAMMER BAGGED & MORE

A week after the failure of Biogen's Alzheimer's drug aducanumab , the ripple effects are still being felt-and not just by Biogen,...

Understanding the potential uses of strontium in treating fatty liver disease

UNDERSTANDING THE POTENTIAL USES OF STRONTIUM IN TREATING FATTY LIVER DISEASE

Chinese researchers test the effect of strontium, an alkaline earth metal, on endoplasmic reticulum stress in nonalcoholic fatty liver...

 
 
 
Yeah, Cocktails Are Cool, but Have You Tried These Refreshing Mocktails?

YEAH, COCKTAILS ARE COOL, BUT HAVE YOU TRIED THESE REFRESHING MOCKTAILS?

Nonalcoholic cocktails are good, if not better, than sugary alcoholic beverages, and you can literally taste why. Mocktails can be...

Genfit, developing drugs for NASH, to trade on Nasdaq

GENFIT, DEVELOPING DRUGS FOR NASH, TO TRADE ON NASDAQ

The company, one of several developing drugs for the growing fatty liver disease, said in an SEC filing that it would sell its shares...

 
 
 
Nonalcoholic fatty liver disease, commonly associated with diabetes, increases the risk of heart disease, and liver, colorectal, and breast cancers

NONALCOHOLIC FATTY LIVER DISEASE, COMMONLY ASSOCIATED WITH DIABETES, INCREASES THE RISK OF HEART DISEASE, AND LIVER, COLORECTAL, AND BREAST CANCERS

In a new study that was published in the Journal of Hepatology, researchers were able to surmise that nonalcoholic fatty liver disease...

Diet Low in Free Sugars Improves Fatty Liver Disease in Children

DIET LOW IN FREE SUGARS IMPROVES FATTY LIVER DISEASE IN CHILDREN

If a child with nonalcoholic fatty liver disease consumes a very low amount of sugars in their diet, both fat and inflammation in the...

 
 
 

STUDY SHOWS LOW-SUGAR DIET EFFECTIVE IN BOYS WITH NONALCOHOLIC FATTY LIVER DISEASE

 
 
 
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More

BIO ROUNDUP: 2019 TRIALS, PILGRIM PRICE CHAT, PRE-XMAS SALES & MORE

It's beginning to look a lot like, well, the last roundup of the year, with plenty of news to pack in before our holiday breather....

15 For '19: Key Clinical Data to Watch For Next Year

15 FOR '19: KEY CLINICAL DATA TO WATCH FOR NEXT YEAR

On Monday, Xconomy began our annual look ahead at clinical trials that could define biotech and have profound healthcare effects in...